PPIDT00126

Drug Information
NameEpratuzumab
SequenceNot Available
DrugBank_IDDB04958
Typebiotech
IndicationInvestigated for use/treatment in leukemia (lymphoid), lymphoma (non-hodgkin's), and systemic lupus erythematosus.

Dosage Forms
Form Route Strength
No dosage records.
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P20273 CD22 B-cell receptor CD22 Homo sapiens antibody|regulator Link